[Table/Fig-3]:

Degree of significance as seen after statistically analysing the serum AAT levels of the VKC patients, as compared to respective controls (by applying unpaired t-test)

Group/sub-groups	AAT level (mg/ml) of		p-value (unpaired t-test)
	Patients	Respective Controls
VKC patients (acute disease)	2.80 ± 0.42	2.31 ± 0.21	< 0.01
Males	2.82 ± 0.42	2.34 ± 0.22	< 0.01
Females	2.77 ± 0.40	2.26 ± 0.18	< 0.01
≤15 years	2.83 ± 0.42	2.37 ± 0.10	< 0.01
16-20 years	2.85 ± 0.45	2.27 ± 0.22	< 0.01
21-25 years	2.80 ± 0.35	2.28 ± 0.25	< 0.01
>25 years	2.74 ± 0.29	2.40 ± 0.19	< 0.03
Mild/Moderate	2.76 ± 0.41	2.31 ± 0.21	< 0.01
Severe	3.09 ± 0.25	2.31 ± 0.21	< 0.001
VKC patients (after treatment)	2.48 ± 0.26	2.31 ± 0.21	> 0.08
Males	2.51 ± 0.28	2.34 ± 0.22	> 0.08
Females	2.44 ± 0.23	2.26 ± 0.18	> 0.07
≤15 years	2.52 ± 0.29	2.37 ± 0.10	> 0.08
16-20 years	2.46 ± 0.25	2.27 ± 0.22	> 0.07
21-25 years	2.43 ± 0.21	2.28 ± 0.25	> 0.08
>25 years	2.49 ± 0.17	2.40 ± 0.19	> 0.10
Mild/Moderate	2.43 ± 0.24	2.31 ± 0.21	> 0.10
Severe	2.88 ± 0.21	2.31 ± 0.21	< 0.01